News
Boehringer Ingelheim achieves further growth in first half of 2012
The pharmaceutical company Boehringer Ingelheim has grown again in the current financial year. In the first half of 2012, currency-adjusted sales increased by 6.8% compared with the previous year to €7.1 billion. The increased sales...
News
Pfizer and AstraZeneca enter into agreement for over-the-counter Nexium
Pfizer Inc. announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD). ...
News
Grapefruit juice lets patients take lower dose of cancer drug
 A glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself, according to a new clinical...
News
Lundbeck on track to meet financial expectations and renew its product portfolio
H. Lundbeck A/S (Lundbeck) reports first half revenue of DKK 6,829 million, excluding Lexapro® in the US, an increase of 1% compared to the first half of 2011. EBITDA and EBIT, excluding restructuring costs...
News
Bristol-Myers Squibb Foundation awards $1.6 million in grants
The Bristol-Myers Squibb Foundation announced $1.6 million in grants to four health care institutions in India that will help improve diabetes education, prevention and care and increase health care worker capacity in rural and tribal areas and among...
News
AcelRx sufentanil NanoTab pain products gain additional US patents
The US Patent and Trademark Office (USPTO) has issued two additional patents to AcelRx Pharmaceuticals' sufentanil NanoTab pain products. Â The patent entitled Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain claims...
News
Rejected Alzheimer’s drug shows new potential
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read